GO:0016260 L-selenocysteine biosynthetic process: Selenoprotein Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016260 describes the chemical reactions and pathways that form L-selenocysteine, the 21st amino acid and essential component of glutathione peroxidase and other selenoproteins.
• Selenocysteine biosynthesis is a tRNA-dependent process that recodes UGA codons from stop to selenocysteine insertion, requiring SEPHS2, SEPSECS, PSTK, EEFSEC, SECISBP2 and the dedicated tRNA-Sec.
• Selenium is incorporated co-translationally into selenoproteins; insufficient selenium or defects in this pathway impair antioxidant defense and redox homeostasis.
• Selenocysteine biosynthesis intersects with ferroptosis, cancer cell survival and detoxification of selenium, making it a target for oncology and metabolic research.
• Dysregulation of selenocysteine synthesis and selenoproteins is linked to cancer, neurodegeneration and endocrine dysfunction.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of GO:0016260 genes in human cells.
Description
L-selenocysteine is a rare but essential amino acid that is co-translationally inserted into selenoproteins, where it often sits in the active site and confers unique redox chemistry. The Gene Ontology term GO:0016260, L-selenocysteine biosynthetic process, captures the enzymatic steps that convert selenium donors into this amino acid and deliver it to the translational machinery. Because selenocysteine is not encoded directly by the standard genetic code, its biosynthesis is tightly coupled to a specialized tRNA and a dedicated protein machinery. Understanding this pathway is central to selenium biology, redox regulation and the growing field of selenoprotein research. From a research perspective, GO:0016260 matters because selenoproteins such as glutathione peroxidase-1 (GPX1) and thioredoxin reductase (TXNRD) depend on an adequate supply of L-selenocysteine. Perturbations in this pathway alter cellular redox balance, influence ferroptosis sensitivity and affect cancer cell survival. In addition, selenium detoxification and selenocysteine metabolism are emerging as metabolic vulnerabilities in tumors. This article summarizes the authoritative QuickGO definition, the molecular steps, the key genes and the experimental models used to study L-selenocysteine biosynthesis. Researchers studying this process need reliable, causally validated cell models because many selenoprotein phenotypes are context-dependent and sensitive to selenium availability. The sections below integrate published literature on the pathway, its regulation, its disease relevance and the CRISPR-based methods that can be used to interrogate it.
L-selenocysteine biosynthetic process At A Glance
| GO ID | GO:0016260 |
|---|---|
| GO term | L-selenocysteine biosynthetic process |
| Ontology | biological_process |
| Synonym | selenocysteine anabolism; selenocysteine biosynthesis; selenocysteine formation; selenocysteine synthesis |
| Major function | Formation of L-selenocysteine for co-translational incorporation into selenoproteins such as glutathione peroxidase |
| Key substrates | Selenide/selenophosphate and seryl-tRNA(Sec) |
| Key enzymes | SEPHS2, PSTK, SEPSECS |
| Key factors | tRNA-Sec, EEFSEC, SECISBP2, SELENOF |
| Cellular context | Cytoplasm and membrane-associated translation machinery |
What Is GO:0016260?
GO:0016260, L-selenocysteine biosynthetic process, is defined by QuickGO as the chemical reactions and pathways resulting in the formation of L-selenocysteine, an essential component of glutathione peroxidase and some other proteins. In practice, this term covers the tRNA-dependent conversion of selenium donors into selenocysteine and its delivery to the ribosome for incorporation into selenoproteins.
Why Is L-selenocysteine biosynthetic process Important in Cell Biology?
L-selenocysteine biosynthesis is important because it supplies the reactive selenol group that gives selenoproteins their high catalytic efficiency in redox reactions. Without this pathway, cells cannot synthesize glutathione peroxidase and thioredoxin reductase, leading to oxidative stress, altered ferroptosis sensitivity and impaired selenium detoxification. Consequently, GO:0016260 is relevant to cancer biology, antioxidant defense and metabolic disease research.
• Provides L-selenocysteine for glutathione peroxidase, a major peroxide-detoxifying enzyme.
• Supports thioredoxin reductase function and cellular redox homeostasis.
• Modulates ferroptosis sensitivity through selenoprotein-dependent lipid peroxide control.
• Influences cancer cell survival via selenium detoxification and selenoprotein synthesis.
• Links dietary selenium status to protein synthesis and stress responses.
• Contributes to membrane-bound selenoprotein function and secretory pathways.
• Dysregulation is associated with cancer and oxidative damage.
• Provides mechanistic insight into UGA recoding and translational control.
• Enables study of selenoprotein-related endocrine and metabolic phenotypes.
• Offers targets for redox-directed therapeutics and biomarker discovery.
What Happens During L-selenocysteine biosynthetic process?
Selenophosphate generation by SEPHS2
In simple terms: The cell first activates selenium into a reactive donor molecule.
Selenocysteine biosynthesis begins with the conversion of selenide to selenophosphate, a high-energy selenium donor, by selenophosphate synthetase 2 (SEPHS2). This step commits selenium to the selenocysteine pathway and is a key point of regulation in selenium metabolism.
Aminoacylation and phosphorylation of tRNA-Sec
In simple terms: A dedicated tRNA is loaded with serine and then modified.
The specialized tRNA-Sec is first aminoacylated with serine by seryl-tRNA synthetase, and the seryl moiety is subsequently phosphorylated by PSTK to form phosphoseryl-tRNA-Sec. This tRNA is the scaffold on which selenocysteine is built, distinguishing the pathway from standard amino acid synthesis.
Conversion to selenocysteinyl-tRNA by SEPSECS
In simple terms: The activated selenium is attached to the tRNA-bound serine to make selenocysteine.
SEPSECS (SepSecS) catalyzes the replacement of the phosphate group on phosphoseryl-tRNA-Sec with selenophosphate, yielding selenocysteinyl-tRNA-Sec. This is the defining enzymatic step of GO:0016260 and requires the selenophosphate produced by SEPHS2.
Delivery to the ribosome and UGA recoding
In simple terms: The finished selenocysteine is brought to the ribosome and inserted at a special UGA codon.
Selenocysteinyl-tRNA-Sec is delivered to the ribosome by the dedicated elongation factor EEFSEC, which cooperates with SECISBP2 bound to a SECIS element in the selenoprotein mRNA. This allows UGA, normally a stop codon, to be recoded as selenocysteine, coupling biosynthesis directly to selenoprotein translation.
Membrane-associated selenoprotein maturation
In simple terms: Some selenoproteins are processed at membranes after selenocysteine insertion.
A subset of selenoproteins is membrane-bound, and their maturation involves membrane-associated translation and processing steps that depend on an adequate supply of L-selenocysteine. This links GO:0016260 to secretory and membrane protein biology.
Key Genes Involved in GO:0016260 L-selenocysteine biosynthetic process
The following genes and proteins are central to L-selenocysteine biosynthesis and its co-translational incorporation into selenoproteins.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SEPHS2 | Synthesizes selenophosphate donor | Rate-limiting selenium activation; knockout alters selenoprotein levels |
| SEPSECS | Converts phosphoseryl-tRNA to selenocysteinyl-tRNA | Core enzyme of GO:0016260; loss impairs selenoprotein synthesis |
| PSTK | Phosphorylates seryl-tRNA-Sec | Required intermediate step; target for pathway dissection |
| SARS1 | Aminoacylates tRNA-Sec with serine | Upstream tRNA charging step |
| EEFSEC | Delivers selenocysteinyl-tRNA to ribosome | Translation factor for UGA recoding |
| SECISBP2 | Binds SECIS element in selenoprotein mRNAs | Determines selenoprotein mRNA recoding efficiency |
| TRU-TCA1-1 | tRNA-Sec gene (tRNA-Sec) | Scaffold for selenocysteine synthesis |
| GPX1 | Glutathione peroxidase using selenocysteine | Major redox enzyme; disease relevance |
| GPX4 | Lipid peroxide reductase | Ferroptosis regulation |
| TXNRD1 | Thioredoxin reductase | Redox homeostasis; selenoprotein |
| TXNRD2 | Mitochondrial thioredoxin reductase | Mitochondrial redox control |
| SELENOF | Membrane-bound selenoprotein | Membrane selenoprotein biology |
| SELENOP | Secreted selenoprotein | Selenium transport and status |
| SELENOW | Selenoprotein W | Redox-related selenoprotein |
| SELENOK | Membrane selenoprotein | Endoplasmic reticulum membrane function |
| SELENOS | Membrane selenoprotein | ER stress and membrane biology |
| SELENOT | Thioredoxin-like selenoprotein | Redox regulation |
| SELENOH | Selenoprotein H | Nuclear redox and transcription |
How Is L-selenocysteine biosynthetic process Regulated?
L-selenocysteine biosynthesis is regulated by selenium availability, because selenium deficiency limits selenophosphate production and reduces selenoprotein synthesis. The pathway is also controlled at the level of tRNA-Sec charging and SECIS-dependent recoding, which determine how efficiently UGA codons are read as selenocysteine. In addition, selenium detoxification pathways influence flux through selenocysteine metabolism and can affect cancer cell survival. Membrane-associated selenoprotein maturation adds another layer of regulation for a subset of selenoproteins.
L-selenocysteine biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GPX1 | Oxidative stress and cancer biology | GPX1 knockout and overexpression cell lines |
| GPX4 | Ferroptosis sensitivity | GPX4 point-mutation and knockout models |
| SEPHS2 | Selenium metabolism and cancer survival | SEPHS2 knockout in cancer cell lines |
| SEPSECS | Impaired selenoprotein synthesis | SEPSECS knockout and rescue models |
| TXNRD1 | Redox homeostasis and cancer | TXNRD1 knockout and inhibitor studies |
Cancer and redox imbalance
Selenocysteine biosynthesis supports glutathione peroxidase and thioredoxin reductase, which protect cells from oxidative damage. Altered selenoprotein synthesis and selenium detoxification are linked to cancer cell survival and proliferation, and L-selenocysteine itself can induce apoptosis in HepG-2 cells through reactive oxygen species-mediated signaling.
Ferroptosis and lipid peroxidation
Selenoprotein-dependent control of lipid peroxides is a key determinant of ferroptosis, a form of regulated cell death driven by polyunsaturated fatty acid peroxidation. Because GPX4 requires L-selenocysteine, defects in GO:0016260 can sensitize cells to ferroptosis.
Selenium metabolism disorders
Insufficient selenium or impaired selenocysteine synthesis reduces selenoprotein activity and is associated with oxidative stress-related pathology. Selenium transport and metabolism are therefore central to understanding systemic effects of this pathway.
Membrane selenoprotein dysfunction
Membrane-bound selenoproteins depend on L-selenocysteine for their redox functions, and their dysfunction has been linked to cellular stress and disease processes.
From L-selenocysteine biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SEPHS2 required for selenoprotein synthesis? | SEPHS2 knockout cell line |
| Does loss of SEPSECS impair UGA recoding? | SEPSECS knockout with selenoprotein reporter |
| How does GPX4 mutation affect ferroptosis? | GPX4 point-mutation knock-in |
| Can selenocysteine synthesis be monitored in live cells? | Tagged knock-in of pathway factors |
| Does overexpression of GPX1 protect against oxidative stress? | GPX1 overexpression cell model |
| Which genes modify selenium detoxification? | CRISPR library screening in cancer cells |
How to Study the L-selenocysteine biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Selenoprotein mRNA abundance | Pathway perturbation profiling |
| Ribo-seq | Translation efficiency at UGA codons | UGA recoding studies |
| Proteomics | Selenoprotein protein levels | Validation of knockout phenotypes |
| CRISPR screening | Gene essentiality and modifiers | Selenium metabolism screens |
| ROS assays | Oxidative stress | Functional readout of pathway loss |
| Lipid peroxidation assays | Ferroptosis sensitivity | GPX4-dependent phenotypes |
| Bioinformatics | Selenoprotein gene annotation | Comparative genomics of selenoproteins |
Transcriptomic and translatomic profiling
RNA-seq and Ribo-seq can measure selenoprotein mRNA levels and translation efficiency, revealing how selenium availability and pathway perturbations affect UGA recoding. These methods help distinguish transcriptional from translational control of GO:0016260 output.
Proteomic detection of selenoproteins
Mass spectrometry-based proteomics can detect selenoproteins and assess whether L-selenocysteine incorporation is altered in knockout or point-mutation models. Selenoprotein-specific enrichment improves sensitivity.
Redox and lipid peroxidation assays
Measuring reactive oxygen species, glutathione status and lipid peroxidation reports the functional consequences of selenocysteine biosynthesis defects, including ferroptosis sensitivity.
CRISPR screening and bioinformatics
Genome-wide CRISPR screens combined with bioinformatic analysis of selenoprotein genes can identify modifiers of selenium metabolism and selenocysteine synthesis. These approaches are useful for discovering pathway vulnerabilities in cancer cells.
How CRISPR Can Be Used to Study GO:0016260 L-selenocysteine biosynthetic process
Knockout
CRISPR knockout of SEPHS2, SEPSECS or PSTK can abolish L-selenocysteine biosynthesis and reveal downstream effects on selenoprotein expression and redox balance. Knockout models are also used to test whether selenium detoxification is required for cancer cell survival.
Point Mutation
Point mutations in catalytic residues of SEPSECS or in SECIS elements can dissect the enzymatic and recoding steps of GO:0016260 without fully deleting the gene. Such models help separate biosynthesis from translation factor functions.
Knock-in
Knock-in of tagged pathway components or reporter selenoproteins allows monitoring of selenocysteine incorporation and trafficking in live cells. Tagged knock-in models are useful for studying membrane-associated selenoprotein maturation.
Overexpression
Overexpression of GPX1 or other selenoproteins can test whether increased selenocysteine utilization protects against oxidative stress or alters ferroptosis sensitivity. Overexpression models complement loss-of-function studies of the pathway.
How EDITGENE Supports L-selenocysteine biosynthetic process Research
Researchers studying L-selenocysteine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in selenoprotein synthesis, redox control or disease phenotypes. EDITGENE provides publication-ready CRISPR cell models and screening services to test these hypotheses directly in relevant human cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for L-selenocysteine biosynthetic process research.
Frequently Asked Questions About L-selenocysteine biosynthetic process
What is GO:0016260 L-selenocysteine biosynthetic process?
GO:0016260 is the Gene Ontology biological process describing the chemical reactions and pathways that form L-selenocysteine, an essential component of glutathione peroxidase and some other proteins.
What genes are involved in L-selenocysteine biosynthetic process?
Key genes include SEPHS2, SEPSECS, PSTK, SARS1, EEFSEC, SECISBP2 and the tRNA-Sec gene, together with selenoprotein genes such as GPX1 and TXNRD1.
Why is L-selenocysteine important for glutathione peroxidase?
L-selenocysteine provides the selenol group in glutathione peroxidase active sites, enabling efficient peroxide detoxification.
How is selenocysteine inserted into proteins?
Selenocysteinyl-tRNA-Sec is delivered to the ribosome by EEFSEC with SECISBP2, allowing UGA codons to be recoded as selenocysteine.
What is the role of SEPHS2 in selenocysteine synthesis?
SEPHS2 produces selenophosphate, the selenium donor used by SEPSECS to form selenocysteinyl-tRNA-Sec.
How does selenium deficiency affect selenocysteine biosynthesis?
Selenium deficiency limits selenophosphate production and reduces selenoprotein synthesis, impairing redox defense.
Is L-selenocysteine biosynthesis related to ferroptosis?
Yes, selenoprotein-dependent control of lipid peroxidation links this pathway to ferroptosis sensitivity.
Can CRISPR knockout be used to study selenocysteine synthesis?
Yes, knockout of SEPHS2, SEPSECS or PSTK is used to dissect the pathway and its downstream effects.
What diseases are linked to selenocysteine metabolism?
Cancer, oxidative stress-related pathology and ferroptosis-associated conditions have been linked to selenoprotein and selenium metabolism.
What methods study L-selenocysteine biosynthetic process?
RNA-seq, Ribo-seq, proteomics, redox assays, lipid peroxidation assays and CRISPR screens are commonly used.
Conclusion
GO:0016260, L-selenocysteine biosynthetic process, defines the tRNA-dependent route that produces the 21st amino acid for selenoprotein synthesis. Its output supports glutathione peroxidase, thioredoxin reductase and other selenoproteins that control redox balance, ferroptosis and selenium detoxification. Because the pathway is sensitive to selenium status and tightly coupled to UGA recoding, it is an attractive area for mechanistic and translational research. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with transcriptomic, proteomic and redox assays, provide a rigorous framework for causal studies of this pathway. EDITGENE supports these efforts with validated cell models and screening services tailored to selenoprotein biology.
References
- 1. Burk RF et al.. 2015. Regulation of Selenium Metabolism and Transport.. Annu Rev Nutr 35:109-34 PMID: 25974694
- 2. Handy DE et al.. 2022. The role of glutathione peroxidase-1 in health and disease.. Free Radic Biol Med 188:146-161 PMID: 35691509
- 3. Santesmasses D et al.. 2020. Bioinformatics of Selenoproteins.. Antioxid Redox Signal 33(7):525-536 PMID: 32031018
- 4. Yang WS et al.. 2016. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.. Proc Natl Acad Sci U S A 113(34):E4966-75 PMID: 27506793
- 5. Carlisle AE et al.. 2020. Selenium detoxification is required for cancer-cell survival.. Nat Metab 2(7):603-611 PMID: 32694795
- 6. Mustacich D et al.. 2000. Thioredoxin reductase.. Biochem J 346 Pt 1(Pt 1):1-8 PMID: 10657232
- 7. Zhang K et al.. 2022. L-Selenocysteine induced HepG-2 cells apoptosis through reactive oxygen species-mediated signaling pathway.. Mol Biol Rep 49(9):8381-8390 PMID: 35716289
- 8. Liu J et al.. 2015. Membrane-bound selenoproteins.. Antioxid Redox Signal 23(10):795-813 PMID: 26168272
